KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Intangibles (2018 - 2025)

Twist Bioscience (TWST) has disclosed Intangibles for 8 consecutive years, with $13.2 million as the latest value for Q4 2025.

  • Quarterly Intangibles fell 7.41% to $13.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 million through Dec 2025, down 7.41% year-over-year, with the annual reading at $13.4 million for FY2025, 7.27% down from the prior year.
  • Intangibles for Q4 2025 was $13.2 million at Twist Bioscience, down from $13.4 million in the prior quarter.
  • The five-year high for Intangibles was $63.9 million in Q4 2021, with the low at $203000.0 in Q1 2021.
  • Average Intangibles over 5 years is $35.6 million, with a median of $35.2 million recorded in 2021.
  • The sharpest move saw Intangibles skyrocketed 30684.73% in 2022, then crashed 73.57% in 2024.
  • Over 5 years, Intangibles stood at $63.9 million in 2021, then dropped by 8.7% to $58.4 million in 2022, then dropped by 8.86% to $53.2 million in 2023, then crashed by 73.28% to $14.2 million in 2024, then decreased by 7.41% to $13.2 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $13.2 million, $13.4 million, and $13.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.